SeqOne is a deep-tech company committed to making personalized medicine a reality. Its AI-powered genomic analysis platform provides clinical decision-support tools that enable molecular laboratories to deliver fast, accurate, and scalable analysis of genetic data for applications in oncology, rare and inherited diseases, and infectious diseases. The company now serves a global customer base of healthcare providers and biopharmaceutical companies across more than 30 countries, supported by strong industry partnerships and an expanding presence in the US market.